trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Adenomyosis D062788 1 associated lipids
Neoplasm Micrometastasis D061206 1 associated lipids
Visceral Pain D059265 1 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Capsule Opacification D058442 1 associated lipids
Intervertebral Disc Degeneration D055959 1 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Classical Lissencephalies and Subcortical Band Heterotopias D054221 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Genomic Instability D042822 7 associated lipids
Mastocytoma D034801 3 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Stroke D020521 32 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Cystadenoma, Serous D018293 1 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Qiang M et al. Epigenetic mechanisms are involved in the regulation of ethanol consumption in mice. 2014 Int. J. Neuropsychopharmacol. pmid:25522411
Wong CH et al. CTSL2 is a pro-apoptotic target of E2F1 and a modulator of histone deacetylase inhibitor and DNA damage-induced apoptosis. 2014 Oncogene pmid:23542171
Xiong J et al. USP22 transcriptional activity is negatively regulated by the histone deacetylase inhibitor trichostatin A. 2014 Mol Med Rep pmid:25323692
Li G et al. Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue. 2014 J. Nutr. pmid:25320182
Shi QQ et al. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling. 2014 Asian Pac. J. Cancer Prev. pmid:25292076
Wei N et al. Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage. 2014 Mol. Cell pmid:25284223
Maldonado L et al. An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine. 2014 Oncotarget pmid:24980822
Wilson-Edell KA et al. RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. 2014 Oncotarget pmid:24970821
Yang XL et al. Effect of trichostatin A on CNE2 nasopharyngeal carcinoma cells--genome-wide DNA methylation alteration. 2014 Asian Pac. J. Cancer Prev. pmid:24969901
Hu Z and Wang J Histone deacetylase inhibitor induces the expression of select epithelial genes in mouse utricle sensory epithelia-derived progenitor cells. 2014 Cell Reprogram pmid:24945595
Ma H et al. HSPC117 is regulated by epigenetic modification and is involved in the migration of JEG-3 cells. 2014 Int J Mol Sci pmid:24941254
Thangavel J et al. Combinatorial therapy with acetylation and methylation modifiers attenuates lung vascular hyperpermeability in endotoxemia-induced mouse inflammatory lung injury. 2014 Am. J. Pathol. pmid:24929240
Mathiyalagan P et al. The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart. 2014 Nucleic Acids Res. pmid:24137001
Zhang YW et al. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer. 2014 Epigenetics pmid:24699858
Boyer JG et al. Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. 2014 Hum. Mol. Genet. pmid:24691550
Deneberg S et al. microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia. 2014 Epigenetics pmid:24686393
Zuo X et al. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI. 2014 Oncol. Rep. pmid:24676336
Aune SE et al. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. 2014 J. Mol. Cell. Cardiol. pmid:24632412
Yuan TF et al. The epigenetics changes in Parkinson's disease: a novel therapeutic target. 2014 CNS Neurosci Ther pmid:24629108
Felisbino MB et al. Changes in chromatin structure in NIH 3T3 cells induced by valproic acid and trichostatin A. 2014 J. Cell. Biochem. pmid:24913611
Fetahu IS et al. Calcium-sensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3. 2014 Int. J. Cancer pmid:24691920
Johnson JL et al. The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute UV light exposure. 2014 J. Invest. Dermatol. pmid:24594668
Chu Y et al. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers. 2014 Cell. Mol. Life Sci. pmid:24531693
Herr MJ et al. Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity. 2014 Biochem. Biophys. Res. Commun. pmid:24747564
Cheng X et al. Generation and characterization of gsuα:EGFP transgenic zebrafish for evaluating endocrine-disrupting effects. 2014 Toxicol. Appl. Pharmacol. pmid:24747804
Guo J et al. Effect of 5-aza-2'-deoxycytidine combined with trichostatin A on RPMI-8226 cell proliferation, apoptosis and DLC-1 gene expression. 2014 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:24763005
Tao W et al. Brainstem brain-derived neurotrophic factor signaling is required for histone deacetylase inhibitor-induced pain relief. 2015 Mol. Pharmacol. pmid:25852071
Bieluszewski T et al. AtEAF1 is a potential platform protein for Arabidopsis NuA4 acetyltransferase complex. 2015 BMC Plant Biol. pmid:25849764
Rumbaugh G et al. Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue. 2015 Neuropsychopharmacology pmid:25837283
Acun T et al. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas. 2015 OMICS pmid:25831062
Huisman C et al. Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. 2015 Epigenetics pmid:25830725
Qiao Y et al. Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation. 2015 J. Biol. Chem. pmid:25519907
Mataki H et al. Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. 2015 J. Hum. Genet. pmid:25518741
Jeong SG and Cho GW Trichostatin A modulates intracellular reactive oxygen species through SOD2 and FOXO1 in human bone marrow-mesenchymal stem cells. 2015 Cell Biochem. Funct. pmid:25515622
Dreser N et al. Grouping of histone deacetylase inhibitors and other toxicants disturbing neural crest migration by transcriptional profiling. 2015 Neurotoxicology pmid:26238599
Wu Y et al. Acetylation-dependent function of human single-stranded DNA binding protein 1. 2015 Nucleic Acids Res. pmid:26170237
Singh RD et al. Arsenic exposure causes epigenetic dysregulation of IL-8 expression leading to proneoplastic changes in kidney cells. 2015 Toxicol. Lett. pmid:26008221
Fukui T et al. Histone deacetylase inhibitor attenuates neurotoxicity of clioquinol in PC12 cells. 2015 Toxicology pmid:25758465
Pinz S et al. Deacetylase inhibitors repress STAT5-mediated transcription by interfering with bromodomain and extra-terminal (BET) protein function. 2015 Nucleic Acids Res. pmid:25769527
Sobolewski C et al. Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. 2015 Biomolecules pmid:26343742
Brandão FA et al. Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes. 2015 Virulence pmid:26103530
Alvarez AA et al. The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells. 2015 J. Mol. Neurosci. pmid:24874578
Rodrigues MF et al. Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells. 2015 J. Cell. Biochem. pmid:25510910
Uchida H et al. Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury. 2015 J. Pharmacol. Sci. pmid:26318673
Zhang Y et al. Effect of histone deacetylase on prostate carcinoma. 2015 Int J Clin Exp Pathol pmid:26823840
Li YL et al. Downregulation of growth differentiation factor-15 in trichostatin A-induced apoptosis could play a role in progression of gastric cancer. 2015 Int J Clin Exp Pathol pmid:26339382
Dupré-Aucouturier S et al. Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy. 2015 J. Appl. Physiol. pmid:26112243
Liu J et al. Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice. 2015 Biochem. Biophys. Res. Commun. pmid:26086099
Huang J et al. Trichostatin A reduces cisplatin-induced ototoxicity through the STAT6 signaling pathway. 2015 Int. J. Mol. Med. pmid:26080623
Huan Y et al. Epigenetic Modification Agents Improve Gene-Specific Methylation Reprogramming in Porcine Cloned Embryos. 2015 PLoS ONE pmid:26068219